Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

14
How a powerful inquiry upended one of Australia's grandest companies

2018-06-22 theedgemarkets
SYDNEY (June 22): One of Australia's oldest financial institutions, AMP Ltd, spent years building the country's largest network of financial advisers to recommend its products, and well over a century polishing its brand.
ARG MQBKY IFL MS.PRE AMP MS.PRF AGVNF MS.PRG MCQEF MS.PRA IOOFF MS.PRI MS.PRK IOOFY MS MQG

33
RPT-How the world's biggest private equity oil and gas industry bid collapsed

2018-05-29 reuters
MELBOURNE, May 29 (Reuters) - Blame it on Trump, Iran or Venezuela. Rising oil prices combined with a heavy debt load killed the world’s biggest private equity oil and gas industry deal last week.
ARG RDS.B RDS.A SSLZY MS.PRE MS.PRF AGVNF MS.PRG RDSB RDSA MS.PRA MS.PRI MS.PRK RYDBF MS RYDAF

33
How the world's biggest private equity oil and gas industry bid collapsed - Channel NewsAsia

2018-05-29 channelnewsasia
Blame it on Trump, Iran or Venezuela. Rising oil prices combined with a heavy debt load killed the world's biggest private equity oil and gas industry deal last week.
ARG RDS.B RDS.A SSLZY MS.PRE MS.PRF AGVNF MS.PRG RDSB RDSA MS.PRA MS.PRI MS.PRK RYDBF MS RYDAF

33
How the world's biggest private equity oil and gas industry bid collapsed

2018-05-29 reuters
MELBOURNE (Reuters) - Blame it on Trump, Iran or Venezuela. Rising oil prices combined with a heavy debt load killed the world’s biggest private equity oil and gas industry deal last week.
ARG RDS.B RDS.A SSLZY MS.PRE MS.PRF AGVNF MS.PRG RDSB RDSA MS.PRA MS.PRI MS.PRK RYDBF MS RYDAF

0
In for $705m, out for £1: Wesfarmers abandons UK Bunnings disaster

2018-05-25 theage.com.au
Wesfarmers has abandoned its disastrous attempt to expand its Bunnings Warehouse chain into the United Kingdom and Ireland, and has sold the business for a single British pound.
ARG AGVNF

0
In for $705m, out for £1: Wesfarmers abandons UK Bunnings disaster

2018-05-25 smh.com.au
Wesfarmers has abandoned its disastrous attempt to expand its Bunnings Warehouse chain into the United Kingdom and Ireland, and has sold the business for a single British pound.
ARG AGVNF

0
Australia's Santos Gets Final Sweetened $10.8B Bid From Harbour Energy

2018-05-21 rigzone
May 21 (Reuters) - U.S.-based Harbour Energy made a final offer of $10.8 billion for Australia's Santos Ltd on Monday, hiking its bid for a fifth time in nine months after a steep rise in oil prices and potentially deterring any rival bids.
ARG SSLZY AGVNF

0
Australia's Santos gets final sweetened US$10.8 billion bid from Harbour Energy

2018-05-21 channelnewsasia
Santos Ltd said on Monday it received a revised offer from U.S.-based suitor Harbour Energy, valuing it at US$10.84 billion, up 4.6 percent from an earlier offer.
ARG SSLZY AGVNF

0
This fund manager says it's OK if economy won't 'shoot the lights out'

2018-05-20 theage.com.au
Australia's relatively slow economic growth compared to other parts of the globe is not concerning given the nation's stellar run of years without recession, according to the outgoing chairman of a fund manager.
ARG AGVNF

0
This fund manager says it's OK if economy won't 'shoot the lights out'

2018-05-20 smh.com.au
Australia's relatively slow economic growth compared to other parts of the globe is not concerning given the nation's stellar run of years without recession, according to the outgoing chairman of a fund manager.
ARG AGVNF

53
Cohen & Steers Infrastructure Fund: A Quality CEF To Play A Return To The Yield Trade

2018-04-30 seekingalpha
UTF has significantly underperformed the market since half way through last year. This is in part due to rising bond yields.
ARG FB DB UTF GOOGL ALI AGVNF GOOG

1
'Step one': More action needed from AMP, say major investors

2018-04-30 theage.com.au
AMP investors want more of the company's board members to step aside, including eventually new interim executive chairman Mike Wilkins, and executives to have their pay docked for misbehaviour.
ARG CCLAY CCL AGVNF CCLAF IMF

1
'Step one': More action needed from AMP, say major investors

2018-04-30 smh.com.au
AMP investors want more of the company's board members to step aside, including eventually new interim executive chairman Mike Wilkins, and executives to have their pay docked for misbehaviour.
ARG CCLAY CCL AGVNF CCLAF IMF

7
Fletcher 'makes sense' for Wesfarmers but pressing issue looms large

2018-04-13 theage.com.au
New Zealand construction and industrial materials company Fletcher Building could be the turnaround story Wesfarmers is looking for to revive growth and shareholder returns, some industry watchers say, while others think the conglomerate has more pressing issues to deal with.
ARG FBU FBU FCREY AGVNF FRCEF

7
Fletcher 'makes sense' for Wesfarmers but pressing issue looms large

2018-04-13 smh.com.au
New Zealand construction and industrial materials company Fletcher Building could be the turnaround story Wesfarmers is looking for to revive growth and shareholder returns, some industry watchers say, while others think the conglomerate has more pressing issues to deal with.
ARG FBU FBU FCREY AGVNF FRCEF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ARG / ARGO INVESTMENTS LIMITED on message board site Silicon Investor.

Speculating in Takeover Targets Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG
Plinking,Target-Shooting and other forms of Mayhem Margaret Sangeru0027s Eugenic Legacy of Death, Disease, Depravit
WELLS FARGO SRNE at $1.90 -- Target Price Issued at $20!
TGT: Target Corporation Amsterdam - Largest Adult Theme Park
Shopping For The Ultimate Bargains Your 5 largest stock positions